Research letter

Eruptive keratoacanthomas associated with dupilumab therapy

Corresponding Author

D. Gleeson

[email protected]

orcid.org/0000-0002-7355-9281

East Surrey Hospital, Surrey and Sussex Healthcare NHS Trust, Redhill, UK

Contribution: Conceptualization (lead), Data curation (lead), Formal analysis (lead), Funding acquisition (lead), Investigation (lead), Methodology (lead), Project administration (lead), Resources (lead), Software (lead), Supervision (lead), Validation (lead), Visualization (lead), Writing - original draft (lead), Writing - review & editing (lead)

Search for more papers by this author

S. Cliff,

S. Cliff

East Surrey Hospital, Surrey and Sussex Healthcare NHS Trust, Redhill, UK

Contribution: Conceptualization (supporting), Data curation (supporting), Formal analysis (supporting), Investigation (supporting), Methodology (supporting), Project administration (supporting), Resources (supporting), Supervision (supporting), Validation (supporting), Visualization (supporting), Writing - original draft (supporting), Writing - review & editing (supporting)

Search for more papers by this author

M. Das,

M. Das

East Surrey Hospital, Surrey and Sussex Healthcare NHS Trust, Redhill, UK

Contribution: Conceptualization (supporting), Data curation (supporting), Formal analysis (supporting), Investigation (supporting), Methodology (supporting), Project administration (supporting), Supervision (supporting), Validation (supporting), Writing - original draft (supporting), Writing - review & editing (lead)

Search for more papers by this author

D. Gleeson,

Corresponding Author

D. Gleeson

[email protected]

orcid.org/0000-0002-7355-9281

East Surrey Hospital, Surrey and Sussex Healthcare NHS Trust, Redhill, UK

Search for more papers by this author

S. Cliff,

S. Cliff

East Surrey Hospital, Surrey and Sussex Healthcare NHS Trust, Redhill, UK

Search for more papers by this author

M. Das,

M. Das

East Surrey Hospital, Surrey and Sussex Healthcare NHS Trust, Redhill, UK

Contribution: Conceptualization (supporting), Data curation (supporting), Formal analysis (supporting), Investigation (supporting), Methodology (supporting), Project administration (supporting), Supervision (supporting), Validation (supporting), Writing - original draft (supporting), Writing - review & editing (lead)

Search for more papers by this author

First published: 05 October 2021

https://doi.org/10.1111/bjd.20781

Citations: 4

Funding sources: none.

Conflicts of interest: the authors declare they have no conflicts of interest.

Share a link

Email
Wechat
Bluesky

Graphical Abstract

We would like to present the case of eruptive keratoacanthomas associated with dupilumab therapy, which occurred in an 85-year-old woman receiving biologic therapy for the treatment of atopic dermatitis. With the increasing prevalence of Dupilumab usage, this is an important potential complication of which clinicians should be aware.

References

1Kong HH, Cowen EW, Azad NS et al. Keratoacanthomas associated with sorafenib therapy. J Am Acad Dermatol 2007; 56: 171–2.
10.1016/j.jaad.2006.10.032
PubMed Web of Science® Google Scholar
2Antonov NK, Nair KG, Halasz CL. Transient eruptive keratoacanthomas associated with nivolumab. JAAD Case Rep 2019; 5: 342–5.
10.1016/j.jdcr.2019.01.025
PubMed Google Scholar
3Su F, Viros A, Milagre C et al. RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors. N Engl J Med 2012; 366: 207–15.
10.1056/NEJMoa1105358
CAS PubMed Web of Science® Google Scholar
4He C, Carter A. The metabolic prospective and redox regulation of macrophage polarization. J Clin Cell Immunol 2015; 6: 371.
10.4172/2155-9899.1000371
PubMed Google Scholar
5Goudie DR, D’Alessandro M, Merriman B et al. Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1. Nat Genet 2011; 43: 365–9.
10.1038/ng.780
CAS PubMed Web of Science® Google Scholar
6Zito G, Saotome I, Liu Z et al. Spontaneous tumour regression in keratoacanthomas is driven by Wnt/retinoic acid signalling cross-talk. Nat Commun 2014; 5: 3543.
10.1038/ncomms4543
PubMed Web of Science® Google Scholar
7Lacouture ME, Morris JC, Lawrence DP et al. Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008). Cancer Immunol Immunother 2015; 64: 437–46.
10.1007/s00262-015-1653-0
CAS PubMed Web of Science® Google Scholar
8Mager L, Wasmer M, Rau T et al. Cytokine-induced modulation of colorectal cancer. Front Oncol 2016; 6: 96.
10.3389/fonc.2016.00096
PubMed Web of Science® Google Scholar

Citing Literature

Volume186, Issue2

February 2022

Pages 376-377

Eruptive keratoacanthomas associated with dupilumab therapy

Graphical Abstract

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Eruptive keratoacanthomas associated with dupilumab therapy

Graphical Abstract

References

Citing Literature

References

Related

Information